| European Federation of Internal Medicine

European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Posted on: 26/04/2018 - 13:27

Vaccines matter for each of us: yearly, they prevent 2.7 million people from contracting measles, one million from getting whooping cough and two million babies from getting tetanus. They eradicated smallpox. They stopped polio, a dreadful disease affecting millions of children, in almost all... more

Field of Interest: European Union Medical News

Type: News Feed

Factsheet - Industry reporting via the European Shortages Monitoring Platform (ESMP) during a crisis or MSSG-led preparedness action

Submitted by Anonymous (not verified) on 16 December 2025 - 18:57

Factsheet - Industry reporting via the European Shortages Monitoring Platform (ESMP) during a crisis or MSSG-led preparedness action

Read more about Factsheet - Industry reporting via the European Shortages Monitoring Platform (ESMP) during a crisis or MSSG-led preparedness action

Frequently asked questions on the European Shortages Monitoring Platform (ESMP)

Submitted by Anonymous (not verified) on 16 December 2025 - 17:10

Frequently asked questions on the European Shortages Monitoring Platform (ESMP)

Read more about Frequently asked questions on the European Shortages Monitoring Platform (ESMP)

Human medicines European public assessment report (EPAR): Pradaxa, dabigatran etexilate, Date of authorisation: 17/03/2008, Revision: 45, Status: Authorised

Submitted by Anonymous (not verified) on 16 December 2025 - 16:08

Human medicines European public assessment report (EPAR): Pradaxa, dabigatran etexilate, Date of authorisation: 17/03/2008, Revision: 45, Status: Authorised

Read more about Human medicines European public assessment report (EPAR): Pradaxa, dabigatran etexilate, Date of authorisation: 17/03/2008, Revision: 45, Status: Authorised

Human medicines European public assessment report (EPAR): Ngenla, somatrogon, Date of authorisation: 14/02/2022, Revision: 8, Status: Authorised

Submitted by Anonymous (not verified) on 16 December 2025 - 16:05

Human medicines European public assessment report (EPAR): Ngenla, somatrogon, Date of authorisation: 14/02/2022, Revision: 8, Status: Authorised

Read more about Human medicines European public assessment report (EPAR): Ngenla, somatrogon, Date of authorisation: 14/02/2022, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Matever, levetiracetam, Date of authorisation: 03/10/2011, Revision: 29, Status: Authorised

Submitted by Anonymous (not verified) on 16 December 2025 - 15:50

Human medicines European public assessment report (EPAR): Matever, levetiracetam, Date of authorisation: 03/10/2011, Revision: 29, Status: Authorised

Read more about Human medicines European public assessment report (EPAR): Matever, levetiracetam, Date of authorisation: 03/10/2011, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR): Seffalair Spiromax, salmeterol,fluticasone propionate, Date of authorisation: 26/03/2021, Revision: 3, Status: Authorised

Submitted by Anonymous (not verified) on 16 December 2025 - 15:45

Human medicines European public assessment report (EPAR): Seffalair Spiromax, salmeterol,fluticasone propionate, Date of authorisation: 26/03/2021, Revision: 3, Status: Authorised

Read more about Human medicines European public assessment report (EPAR): Seffalair Spiromax, salmeterol,fluticasone propionate, Date of authorisation: 26/03/2021, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Omforro, midazolam, Status: Application withdrawn

Submitted by Anonymous (not verified) on 16 December 2025 - 15:30

Human medicines European public assessment report (EPAR): Omforro, midazolam, Status: Application withdrawn

Read more about Human medicines European public assessment report (EPAR): Omforro, midazolam, Status: Application withdrawn

European Shortages Monitoring Platform (ESMP): Interoperability with national and pharmaceutical industry systems

Submitted by Anonymous (not verified) on 16 December 2025 - 15:17

European Shortages Monitoring Platform (ESMP): Interoperability with national and pharmaceutical industry systems

Read more about European Shortages Monitoring Platform (ESMP): Interoperability with national and pharmaceutical industry systems

European Shortages Monitoring Platform (ESMP)

Submitted by Anonymous (not verified) on 16 December 2025 - 15:15

European Shortages Monitoring Platform (ESMP)

Read more about European Shortages Monitoring Platform (ESMP)

European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Factsheet - Industry reporting via the European Shortages Monitoring Platform (ESMP) during a crisis or MSSG-led preparedness action

Frequently asked questions on the European Shortages Monitoring Platform (ESMP)

Human medicines European public assessment report (EPAR): Pradaxa, dabigatran etexilate, Date of authorisation: 17/03/2008, Revision: 45, Status: Authorised

Human medicines European public assessment report (EPAR): Ngenla, somatrogon, Date of authorisation: 14/02/2022, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Matever, levetiracetam, Date of authorisation: 03/10/2011, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR): Seffalair Spiromax, salmeterol,fluticasone propionate, Date of authorisation: 26/03/2021, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Omforro, midazolam, Status: Application withdrawn

European Shortages Monitoring Platform (ESMP): Interoperability with national and pharmaceutical industry systems

European Shortages Monitoring Platform (ESMP)

Newsletters

Latest Newsletters

You are here

Newsletters

Latest Newsletters